Drrx stock forecast.
Nov 8, 2023 · DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million.
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.On average, Wall Street analysts predict that Durect 's share price could reach $34.00 by Aug 10, 2024. The average Durect stock price prediction forecasts a potential upside …BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.06% of the time in the same period.Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.7 Jun 2023 ... Bond & Stock Ratings · Conference Call Announcements · Contracts · Cryptocurrency · Dividends · Earnings · Earnings Forecasts & Projections ...
Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.
Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing. DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.
DRRX is a biopharmaceutical company that develops medicines based on its epigenetic regulator and pharmaceutical programs. The stock price forecast is $34.25, an increase of 1,275.50% from the latest price, according to 4 analysts. The company offers ALZET product line for research in mice, rats, and other laboratory animals.DRRX Forecast — Price Target — Prediction for 2024 USD / / / Forecast DURECT Corporation DRRXNASDAQ DRRXNASDAQ 0.6518USD +0.0318 +5.13% At close at Dec 1, 16:49 UTC-8 See on Supercharts Overview …VINCW. Vincerx Pharma, Inc. 1.6100. -0.4200. -20.69%. In this article, we will take a look at the 10 oversold penny stocks to buy. To see more such companies, go directly to 5 Oversold Penny ...
DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...
Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to DRRX in the past 3 months.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372.
Durect Corp Price (DRRX) Daily Price Prediction ChartsDSAC stock forecast for 2023 – 2027. Last updated: November 22, 2023. Are you interested in Duddell Street Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the DSAC stock price in …DURECT stock forecast: Based on undefined Wall Street analysts` predicted price targets for DURECT in the last 3 months, the avarage price target is $NaN, with a high ...The Applied Uv stock price gained 9.13% on the last trading day (Friday, 1st Dec 2023), rising from $0.115 to $0.126. During the last trading day the stock fluctuated 17.43% from a day low at $0.111 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -13.45% for this period. Volume fell on the last day by -337 ...The BigBear.ai Holdings stock price fell by -3.70% on the last day (Wednesday, 29th Nov 2023) from $1.89 to $1.82. During the last trading day the stock fluctuated 10.06% from a day low at $1.79 to a day high of $1.97. The price has risen in 6 of the last 10 days but is still down by -3.19% for this period. Volume has increased on the last day ...U.S. stock index futures edged up on Wednesday as investors awaited Federal Reserve Chair Jerome Powell's speech at a conference to gauge his view on interest rates and the state of the economy. At 9:07 ET, Dow e-minis (1YMc1) were up 0.13% at 34,260. S&P 500 e-minis ES1! were up 0.10% at 4,400.5, while Nasdaq 100 e …
Find the latest Durect Corporation (DRRX) stock forecast, 12-month price target, predictions and analyst recommendations.DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...
U.S. stock index futures edged up on Wednesday as investors awaited Federal Reserve Chair Jerome Powell's speech at a conference to gauge his view on interest rates and the state of the economy. At 9:07 ET, Dow e-minis (1YMc1) were up 0.13% at 34,260. S&P 500 e-minis ES1! were up 0.10% at 4,400.5, while Nasdaq 100 e …Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...Nov 24, 2023 · DRRX Signals & Forecast. There are mixed signals in the stock today. The Durect Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.The Applied Uv stock price gained 9.13% on the last trading day (Friday, 1st Dec 2023), rising from $0.115 to $0.126. During the last trading day the stock fluctuated 17.43% from a day low at $0.111 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -13.45% for this period. Volume fell on the last day by -337 ...DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...DRRX stock has a “B” rating in the Portfolio Grader. Dynavax Technologies (DVAX) Dynavax Technologies DVAX is a commercial-stage biotech company focusing is on getting drugs over the finish line (approval from the Food & Drug Administration and other regulators in other countries) and available for sale.DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...
In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.
Durect Corp [DRRX] stock prices are up 4.33% to $0.65 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DRRX shares have gain 3.03% over the last week, with a monthly amount drifted -73.90%, and not seem to be holding up
A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ... Apr 24, 2023 · Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ... What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system. DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.Stock analysis for Durect Corp (DRRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.DURECT has an Altman Z-Score of -16.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -16.45. Piotroski F-Score. 2. Detailed statistics for DURECT Corporation (DRRX) stock, including valuation metrics, financial numbers, share information and more.
Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?DURECT (DRRX) Stock Forecast & Price Target $0.64 +0.01 (+1.03%) (As of 02:51 PM ET) Compare Today's Range $0.59 $0.65 50-Day Range $0.53 $2.98 52 …Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis. Instagram:https://instagram. mad money lighting roundmosaic fertilizer stockis cash kingcamping world holdings Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ... marketbeat.com - June 2 at 4:40 AM. Tocqueville Asset Management L.P. Has $316,000 Position in DURECT Co. (NASDAQ:DRRX) marketbeat.com - May 19 at 7:46 AM. Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI) markets.businessinsider.com - May 18 at 8:46 AM. commercial real estate reitregistered investment advisors near me SNBR Stock Outlook. Sleep Number updated its outlook for the full year of 2023 in its latest earnings report as well. It now expects diluted EPS to be up to -70 cents while revenue will decrease ...Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom weat. Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...